Attention Deficit Hyperactivity Disorder Clinical Trials
Attention Deficit Hyperactivity Disorder clinical trials evaluate new treatments, behavioral therapies, and medications for attention Deficit Hyperactivity Disorder. Corterve compiles actively recruiting Attention Deficit Hyperactivity Disorder studies from the ClinicalTrials.gov registry so you can search by location and eligibility criteria. Participation is always voluntary and confidential. This information is educational and not medical advice — talk with a licensed clinician about whether a study is right for you.
Recruiting Attention Deficit Hyperactivity Disorder studies
- Developing Brain, Impulsivity and CompulsivityNCT04631042National Institute of Mental Health (NIMH)Bethesda, Maryland
- Mindfulness Intervention for College Students With ADHDNCT06076967NAUniversity of Alabama, TuscaloosaTuscaloosa, Alabama
- Improving ADHD Teen Driving - Virtual RealityNCT06960980NAChildren's Hospital Medical Center, CincinnatiCincinnati, Ohio
- Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHDNCT03781752PHASE4Icahn School of Medicine at Mount SinaiGainesville, Florida
- Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II TrialNCT05608434PHASE1, PHASE2National Institute of Mental Health (NIMH)Bethesda, Maryland
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)NCT04278404Duke UniversityPhoenix, Arizona
- Trigeminal Nerve Stimulation for Children With Prenatal Alcohol ExposureNCT06847165NAUniversity of California, Los AngelesLos Angeles, California
- Neurocognitive Effects of Non-Invasive Near-Infrared Light StimulationNCT05802680NAFrancisco Gonzalez-Lima, PhDAustin, Texas
- Effects of Transcranial Photobiomodulation in ADHDNCT07203092NAFrancisco Gonzalez-Lima, PhDAustin, Texas
- R61/33 - VR Study Phase 4NCT07169760PHASE4Rutgers, The State University of New JerseyBaton Rouge, Louisiana
- ADHD PreSMA Response Inhibition TherapyNCT06325813NAChildren's Hospital Medical Center, CincinnatiCincinnati, Ohio
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric PopulationsNCT04296604NAMassachusetts General HospitalBoston, Massachusetts
See all 22 recruiting Attention Deficit Hyperactivity Disorder trials →
Attention Deficit Hyperactivity Disorder trials by state
Attention Deficit Hyperactivity Disorder trials by metro
Frequently asked questions
- How do I find recruiting Attention Deficit Hyperactivity Disorder clinical trials?
- Corterve aggregates actively recruiting Attention Deficit Hyperactivity Disorder studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Attention Deficit Hyperactivity Disorder clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Attention Deficit Hyperactivity Disorder clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.
